Z. Alipio

Phenotypic correction of murine hemophilia A using an iPS cell-based therapy

L. Fink, D. Ward, Yupo Ma, 2009, Proceedings of the National Academy of Sciences.

Epithelial to mesenchymal transition (EMT) induced by bleomycin or TFG(b1)/EGF in murine induced pluripotent stem cell-derived alveolar Type II-like cells.

L. Fink, D. Ward, Yupo Ma, 2011, Differentiation; research in biological diversity.

Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4

L. Fink, Yupo Ma, R. Lai, 2011, Journal of hematology & oncology.

Dissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemia

D. Krause, L. Silberstein, L. Chai, 2011, Leukemia.

Sustained factor VIII production in hemophiliac mice 1 year after engraftment with induced pluripotent stem cell-derived factor VIII producing endothelial cells.

L. Fink, M. Waner, D. Ward, 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells

Li Chai, L. Fink, D. Ward, 2008, Proceedings of the National Academy of Sciences.

SALL4 is a key regulator of survival and apoptosis in human leukemic cells.

L. Fink, D. Ward, Yupo Ma, 2008, Blood.

SALL 4 is a key regulator of survival and apoptosis in human leukemic cells

L. Fink, D. Ward, Yupo Ma, 2008 .

Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic β-like cells

Milton Waner, L. Fink, M. Waner, 2010, Proceedings of the National Academy of Sciences.

Phenotypic correction of murine hemophilia A using an iPS cell-based therapy

L. Fink, D. Ward, Yupo Ma, 2009, Proceedings of the National Academy of Sciences.